Article

bizjournals.com on 2017-07-24 18:06

Merck launches biosimilar version of J&J blockbuster Remicade

J&J

Related news

J&J and Pfizer Settle Remicade Biosimilar Antitrust Suit jdsupra.com
Sherman , Pennsylvania
J&J: Despite Biosimilar Competition, Remicade® Retains Approximately 94% of Infliximab Volume Share jdsupra.com
California , United States , Switzerland
Patent for J&J’s Remicade invalidated, cheaper version looms reviewtimes.com
Court Says Pfizer's Biosimilar of J&J's Remicade Doesn't Infringe Patent wsj.com
FDA OKs Samsung Bioepis’s Biosimilar Version Of J&J’s Remicade wsj.com
Pfizer to launch cheaper version of J&J immune drug Remicade journalrecord.com
FDA approves 1st cheaper version of J&J’s top drug Remicade reviewtimes.com
South Korea , Europe
FDA approves 1st cheaper version of J&J's top drug Remicade dothaneagle.com
Europe
FDA OKs first cheaper version of Remicade The Salt Lake Tribune
South Korea , Europe , Washington
Patent for J&J's Remicade invalidated The Salt Lake Tribune
Massachusetts , New Jersey , New Brunswick , Trenton
FDA approves biosimilar competition for J&J's Remicade drug bizjournals.com
Europe
FJ&J sales hit by ‘biosimilar’ competition ft.com
Wall Street , South Korea , Europe , New York
Pfizer Accuses J&J of Anticompetitive Business Practices over Remicade Biosimilar jdsupra.com
Pfizer to launch cheaper version of J&J immune drug Remicade smdailyjournal.com
New Jersey , New Brunswick , Bu in , Europe , Switzerland
Celltrion's Proposed REMICADE® Biosimilar Recommended for Approval jdsupra.com
Massachusetts , Canada , India , Japan , South Korea
FDA Approves Inflectra - Celltrion's REMICADE® Biosimilar jdsupra.com
United States , Massachusetts , Canada , India , Japan
Janssen and Celltrion: Remicade Biosimilar Patent Dance jdsupra.com
Pfizer, J&J, Merck evaluating technologies for Zika vaccine Reuters
Bangalore , Texas , United States , Japan , Germany
MPresident Biden meets with CEOs from J&J and Merck mvtelegraph.com
United States , White House